Intended for healthcare professionals


Stockpiling of raw material for oseltamivir is not justified

BMJ 2006; 332 doi: (Published 19 January 2006) Cite this as: BMJ 2006;332:178
  1. Alberto A E Bertelli, research physician (
  1. Department of Human Morphology, University of Milan, via Mangiagalli 31, 20133 Milan, Italy

    Editor—Mudur reports that Roche has granted a sublicence for the production of the antiviral drug oseltamivir (Tamiflu) to an Indian company and points out that the supply of raw material, shikimic acid (extracted from the Chinese spice star anise Illicium verum …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription